ADMA Biologics (ADMA) SEC Filings & 10K Form

$6.81
+0.07 (+1.04%)
(As of 05/3/2024 ET)

Recent ADMA Biologics SEC Filings

DateFilerForm TypeView
04/15/2024
3:35 PM
ADMA Biologics (Filer)
Form DEFA14A
04/15/2024
3:40 PM
ADMA Biologics (Filer)
Form ARS
04/15/2024
3:31 PM
ADMA Biologics (Filer)
Form DEF 14A
04/02/2024
8:00 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/02/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
8:01 PM
ADMA Biologics (Issuer)
Kestenberg-Messina Kaitlin M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
8:48 PM
ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
8:00 PM
ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:44 PM
ADMA Biologics (Subject)
Aisling Capital II LP (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
11:31 AM
ADMA Biologics (Subject)
TEACHERS ADVISORS, LLC (Filed by)
Form SC 13G/A
03/11/2024
11:24 AM
ADMA Biologics (Subject)
TIAA CREF INVESTMENT MANAGEMENT LLC (Filed by)
Form SC 13G/A
03/11/2024
11:19 AM
ADMA Biologics (Subject)
Nuveen Asset Management, LLC (Filed by)
Form SC 13G/A
03/08/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
8:01 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
8:00 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:00 PM
ADMA Biologics (Issuer)
ELMS STEVE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:00 PM
ADMA Biologics (Issuer)
Fong Bryant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:00 PM
ADMA Biologics (Issuer)
Guiheen Lawrence P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:00 PM
ADMA Biologics (Issuer)
KWON YOUNG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Jerrold B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
8:00 PM
ADMA Biologics (Issuer)
FINGER ALISON CECILY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
3:15 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
3:21 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
8:03 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
7:00 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
10:47 AM
ADMA Biologics (Subject)
TEACHERS ADVISORS, LLC (Filed by)
Form SC 13G
02/14/2024
10:50 AM
ADMA Biologics (Subject)
Nuveen Asset Management, LLC (Filed by)
Form SC 13G
02/14/2024
10:37 AM
ADMA Biologics (Subject)
TIAA CREF INVESTMENT MANAGEMENT LLC (Filed by)
Form SC 13G
01/08/2024
7:00 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
8:00 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
3:30 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
3:30 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2023
3:31 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
8:00 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2023
8:02 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
3:45 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Never use this word on your phone (FBI could be watching) (Ad)

This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...

Watch my unredacted video about what I think is coming next right here
10/02/2023
3:46 PM
ADMA Biologics (Issuer)
FINGER ALISON CECILY (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/24/2023
6:53 PM
ADMA Biologics (Issuer)
KWON YOUNG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2023
7:30 PM
ADMA Biologics (Issuer)
Fong Bryant (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
4:09 PM
ADMA Biologics (Subject)
Fong Bryant (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/18/2023
8:46 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2023
8:30 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2023
8:30 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
7:50 PM
ADMA Biologics (Subject)
LENZ BRIAN (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
7:47 PM
ADMA Biologics (Subject)
Grossman Adam S (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2023
6:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2023
8:00 PM
ADMA Biologics (Issuer)
Grossman Adam S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
8:00 PM
ADMA Biologics (Issuer)
LENZ BRIAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:30 PM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2023
6:30 AM
ADMA Biologics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2023
6:31 AM
ADMA Biologics (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ADMA) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners